Senza Spinal Cord Stimulation System – P130022/S039

Senza Spinal Cord Stimulation System – P130022/S039

Price: $ 96.99

4.9(99)

The Senza, Senza II, and Senza Omnia are implanted, rechargeable Spinal Cord Stimulation systems to treat chronic pain in a patient’s trunk or limbs that is difficult to manage.

https://www.bostonscientific.com/content/dam/bostonscientific/neuro/portfolio-group/Precision_Spectra/Precision_Spectra_System_Infinion_940x940.png

Spinal Cord Stimulator Systems - Boston Scientific

http://vertassets.blob.core.windows.net/image/ee90e276/ee90e276-a5c8-47e8-b7d8-ee556750c9a9/450_300_stjudespine.jpg

FDA Approves First Smart Spinal Cord Stimulation Trial System

https://embed-ssl.wistia.com/deliveries/15f1650cee5967619ffad24496e093232310a028.jpg?image_crop_resized=640x361

Nevro Spinal Cord Stimulation in Bellevue and Seattle

https://onlinelibrary.wiley.com/cms/asset/c1dece78-7b03-40e3-a762-bad1c5920e8b/advs5369-fig-0009-m.jpg

Advanced Temporally‐Spatially Precise Technologies for On‐Demand

https://neuronewsinternational.com/wp-content/uploads/sites/3/2015/09/senza-rct-results-published-in-anesthesiology.jpg

FDA approves Senza spinal cord stimulation system delivering HF10

https://onlinelibrary.wiley.com/cms/asset/9f3fffc2-7233-405b-ab01-30bd659fa245/papr13124-fig-0002-m.jpg

Novel spinal cord stimulation system with a Battery‐Free micro

https://neuronewsinternational.com/wp-content/uploads/sites/3/2016/01/cms-approves-transitional-pass-through-payment-for-outpatient-use-of-nevros-senza-spinal-cord-stimulation-system-448x295.gif

Nevro receives CE mark for full-body MRI conditional labelling

https://lookaside.fbsbx.com/lookaside/crawler/media/?media_id=444971886203402

Dr. Stephens - Interventional Pain Physician - Implanted the first

https://www.thelancet.com/cms/attachment/c2eb7026-bd83-419b-ae15-d0e7697fd1d2/gr1_lrg.jpg

Spinal cord injury: time to move - The Lancet

https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs41983-022-00472-y/MediaObjects/41983_2022_472_Fig1_HTML.png

Advances in targeting central sensitization and brain plasticity